James Healy - Jul 1, 2024 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role
Director
Signature
/s/ Nathalie Auber, Attorney-in-Fact
Stock symbol
RAPP
Transactions as of
Jul 1, 2024
Transactions value $
$1,079,575
Form type
4
Date filed
7/3/2024, 08:04 PM
Previous filing
Jul 2, 2024
Next filing
Jul 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAPP Common Stock Purchase $81.6K +3.54K +13.9% $23.08* 29K Jul 1, 2024 By CRESTLINE SUMMIT PINNACLE MASTER, L.P. F1, F2
transaction RAPP Common Stock Purchase $86.3K +3.57K +12.3% $24.21* 32.6K Jul 1, 2024 By CRESTLINE SUMMIT PINNACLE MASTER, L.P. F2, F3
transaction RAPP Common Stock Purchase $114K +4.54K +13.96% $25.02* 37.1K Jul 1, 2024 By CRESTLINE SUMMIT PINNACLE MASTER, L.P. F2, F4
transaction RAPP Common Stock Purchase $66.7K +2.56K +6.9% $26.06* 39.7K Jul 1, 2024 By CRESTLINE SUMMIT PINNACLE MASTER, L.P. F2, F5
transaction RAPP Common Stock Purchase $87.7K +3.8K +21.27% $23.08* 21.7K Jul 1, 2024 By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP F1, F6
transaction RAPP Common Stock Purchase $92.7K +3.83K +17.67% $24.21* 25.5K Jul 1, 2024 By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP F3, F6
transaction RAPP Common Stock Purchase $122K +4.88K +19.14% $25.02* 30.4K Jul 1, 2024 By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP F4, F6
transaction RAPP Common Stock Purchase $71.6K +2.75K +9.05% $26.06* 33.1K Jul 1, 2024 By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP F5, F6
transaction RAPP Common Stock Purchase $83.8K +3.63K +13.81% $23.08* 29.9K Jul 1, 2024 By Crestline Summit Master, SPC - PEAK SP F1, F7
transaction RAPP Common Stock Purchase $88.5K +3.66K +12.23% $24.21* 33.6K Jul 1, 2024 By Crestline Summit Master, SPC - PEAK SP F3, F7
transaction RAPP Common Stock Purchase $117K +4.66K +13.89% $25.02* 38.2K Jul 1, 2024 By Crestline Summit Master, SPC - PEAK SP F4, F7
transaction RAPP Common Stock Purchase $68.4K +2.63K +6.87% $26.06* 40.9K Jul 1, 2024 By Crestline Summit Master, SPC - PEAK SP F5, F7
holding RAPP Common Stock 1.86M Jul 1, 2024 By Sofinnova Venture Partners XI, L.P. F8
holding RAPP Common Stock 18.6K Jul 1, 2024 By Sofinnova Synergy Master Fund LP F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.55 to $23.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The shares are directly held by CRESTLINE SUMMIT PINNACLE MASTER, L.P. ("Pinnacle LP"). Sofinnova Synergy GP, LLC ("Synergy Fund GP") is the general partner of Pinnacle LP. The Reporting Person is a managing member of Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by Pinnacle LP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.59 to $24.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.59 to $25.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.61 to $26.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F6 The shares are directly held by Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP ("APEX SP"). Synergy Fund GP is the general partner of APEX SP. The Reporting Person is a managing member of Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by APEX SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
F7 The shares are directly held by Crestline Summit Master, SPC - PEAK SP ("PEAK SP"). Synergy Fund GP is the general partner of PEAK SP. The Reporting Person is a managing member of Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by PEAK SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
F8 The shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
F9 The shares are directly held by Sofinnova Synergy Master Fund LP ("Synergy Fund"). Synergy Fund GP is the general partner of Synergy Fund. The Reporting Person is a managing member of Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by Synergy Fund. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.